Hyperlipidemia Flashcards
Sources of cholesterol
- Liver production (75-80%)
- Dietary
Dyslipidemia definition
- High cholesterol
- High TG
- High cholesterol & TG
- High LDL
Chylomicron
Lipoprotein (containing digested fats) formed and absorbed in small intestine
Types of triglycerides
- Saturated (meat, dairy, some veggies, exotic oils)
- Monounsaturated (olive/canola oil, peanuts, avocados)
- Polyunsaturated (essential fats, sunflower/soybean oil, cold water fish)
Which triglycerides have the greatest impact on increasing LDL?
Saturated
The higher density of lipoprotein means ____ lipid content
Lower
Function of HDL
- Transports cholesterol back to liver
- There it is used to make bile salts OR excreted
Cholesterol is a critical component of:
- Cell membranes
- Bile
Cholesterol is a precursor of:
Steroid hormones
Lipoprotein =
Apoprotein + lipid
Apoproteins
Transport cholesterol
What is the rate limiting step in the synthesis of cholesterol?
HMG CoA reductase
Primary hyperlipidemia
- Single or multiple genetic mutations
- Results in overproduction or defective clearance
Types of primary hyperlipidemia
- Familial hypercholesterol (Type IIa, increased LDL)
- Familial combined (increased LDL and VLDL)
- Familial hyperTG (increased TG, autosomal dominant)
Which type of primary hyperlipidemia has the highest risk for pancreatitis?
Familial hypertriglyceridemia
Type IIa familial hypercholesterolemia - lab findings, clinical features, therapy
- TG normal, LDL high, chol high
- Onset at all ages
- Premature vascular disease
- Xanthomas
- Tx = low fat/chol diet, meds, intestinal bypass
Secondary hyperlipidemia
- Sedentary lifestyle
- Excessive intake of bad fats and cholesterol
- DM or metabolic syndrome
- ETOH, tobacco
- CKD, hypothyroid, liver disease
- Meds
Pathophys of atherosclerosis
- Cholesterol deposits in vascular walls
- Fatty streaks become fibrous plaques
- Inflammation causes plaque instability leading to rupture
Lipidemia retinalis
Cream colored blood vessels in the fundus (TG > 2000 mg/dL)
Definition of metabolic syndrome
- Cluster of common conditions that increases T2DM and CVD risk
- 3 criteria (abdominal obesity, impaired gluc tolerance, decreased HDL, increased TG, HTN)
Framingham risk score
Used to determine CVD risk in asymptomatic patients within 10 years
ATP III guidelines for hyperlipidemia screening
Adults over 20 yo every 5 years
Desirable serum total cholesterol
Optimal serum LDL
LDL goal for drug therapy
30-40% reduction in LDL
60% reduction in LDL is ideal
Optimal serum TG
Optimal serum HDL
60+ mg/dL
Elevated HDL is a negative risk factor. Explain what that means
It removes one risk factor from the total count
For every 1% decrease in serum cholesterol, CVD risk is ____
Decreased by 2%
T/F: Dietary intake of saturated fat has much more of an influence on serum cholesterol levels than dietary cholesterol intake.
TRUE
Total dietary fat intake should be ____% of total calories
20-35%
When is bariatric surgery considered?
BMI 40+ or 35+ with comorbidities
Define glycemic index
A measure of the rate of the rise in serum glucose from various food sources
Consider high dose statin if 10 yr risk by new calculator is:
7.5%+
Dyslipidemia treatment goals for those without comorbidities and with T2DM/CVD?
-LDL
Treatment options for lowering LDL
- Lifestyle mods
2. Meds (4 classes - statins, bile acid sequestrants, fibric acids, nicotinic acids)
What are statins used for?
Both primary and secondary prevention
What are the only lipid lowering agents considered safe in pregnancy?
Bile acid sequestrants
Side effects of fibric acid derivatives?
- Cholelithiasis
- Hepatitis
- Myositis
What should you advise a patient to do if omega 3 pills are causing GERD?
Place capsules in freezer
Which statin is the only one not metabolized by CYP450?
Pravastatin
Which drug classes lower LDL?
- Bile acid sequestrants
- Nicotinic acids
- Fibrates
Which drug classes lower TGs?
- Fibrates
- Nicotinic acids
- Omega 3
Which drug classes enhance HDL?
- Statins
- Fibrates
- Bile acid sequestrants
- Nicotinic acids
Side effects of PCSK9 inhibitors
Neurocognitive events reported during trials